JB Capital’s Quest Diagnostics DGX Stock Holding History

JB Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,975	Closed	-$1.06M	–	179
2022 Q2	$1.06M	Buy	7,975 +748	+10%	+$102K	0.11%	94
2022 Q1	$990K	Buy	+7,227	New	+$1.01M	0.1%	103

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JB Capital's DGX Position: Q3 2022 in Review

JB Capital sold out of Quest Diagnostics (DGX) in Q3 2022, closing a stake of 7,975 shares — an estimated $1.06M sold.

JB Capital first reported a position in DGX in Q1 2022 and held it in 2 quarters. The position peaked at $1.06M in Q2 2022. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

JB Capital reported no remaining Quest Diagnostics position as of Q3 2022 after selling out during the quarter.
JB Capital sold 7,975 Quest Diagnostics shares in Q3 2022, an estimated $1.06M.
JB Capital first reported a position in Quest Diagnostics in Q1 2022 and held it in 2 quarters.
JB Capital's Quest Diagnostics position peaked at $1.06M in Q2 2022.
808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on JB Capital's 13F filing for Q3 2022, filed 14 Oct 2022.